Exploring 4,7-Disubstituted Pyrimido[4,5-d]pyrimidines as Antiviral and Anticancer Agents
Eleftheria A. Georgiou, Konstantinos Paraskevas, Christina Koutra, Leentje Persoons, Dominique Schols, Steven De Jonghe, Ioannis K. Kostakis · 2024
Read Exploring 4,7-Disubstituted Pyrimido[4,5-d]pyrimidines as Antiviral and Anticancer Agents by Eleftheria A. Georgiou, Konstantinos Paraskevas, Christina Koutra, Leentje Persoons, Dominique Schols, Steven De Jonghe, Ioannis K. Kostakis (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11643962.txt.
Description
Drug hunters love a scaffold that hits two enemies at once, and Eleftheria Georgiou and six co-authors built thirteen new compounds on one such frame in a 2024 paper. The frame is a double-ring pyrimidine structure, decorated at two positions, assembled by a simple route from thiourea.
Tested across eight cancer cell lines, two of the compounds stood out against blood cancers. Against viruses, the whole set was screened, and versions carrying a cyclopropylamino group plus an aminoindane part hit human coronavirus 229E hard. Three compounds earned the label of strong candidates for follow-up. The authors argue the scaffold deserves a place in antiviral design against human coronaviruses, with the anticancer signals as a bonus worth chasing separately.
Catalog record
| CREATOR | Eleftheria A. Georgiou, Konstantinos Paraskevas, Christina Koutra, Leentje Persoons, Dominique Schols, Steven De Jonghe, Ioannis K. Kostakis |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |